Gene Expression Markers for Predicting Overall Survival in Subjects Treated With Sipuleucel-T
Copyright © Targeted News Service 2024
2024-04-30
ALEXANDRIA, Virginia, April 30 -- DENDREON PHARMACEUTICALS LLC, Seal Beach, California has been assigned a patent (No. US 11970743 B2, initially filed Sept. 9, 2019) developed by five inventors James B. Trager, Seattle, Washington; Nadeem A. Sheikh, Seattle, Washington; Debraj GuhaThakurta, Bellevue, Washington; Harini Kandadi, East Windsor, New Jersey; and Li-Qun Fan, Bellevue, Washington, for "Gene expression markers for predicting overall survival in subjects treated with sipuleucel-T." . . .